CompoAtlas

SunFiber

SunFiber, licence 80123544: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Other names
Fibre4
Licence holder
WN Pharmaceuticals Ltd
NPN or DIN-HM
80123544
Status
Active licence
Licence date
15 March 2023
Revision date
Not provided
Form
Poudre
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Gomme de Guar partiellement hydrolysée

Source : Partially hydrolysed guar gum

5.0 gNot calculated

Non-medicinal ingredients

Acide citrique, Saveur, Poudre d'enveloppes d'Oryza sativa (Riz), Extrait de feuilles de stévia, Acide L-malique

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18.0 ansminimum: 1.0 Portions ; maximum: 2.0 Portions1.0 Jour(s)
Enfants et Adolescentsminimum: 12.0 ans ; maximum: 17.0 ans1.0 Portions1.0 Tous les jours
Adultesminimum: 18.0 ansminimum: 1.0 Portions ; maximum: 2.0 Portions1.0 Tous les jours
Enfants et Adolescentsminimum: 8.0 ans ; maximum: 17.0 ans1.0 Portions1.0 Tous les jours
Adultesminimum: 18.0 ans1.0 Portionsminimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of fibre for the maintenance of healthy gastrointestinal functions. Helps to improve intestinal regularity including constipation and/or diarrhea. Helps to improve bowel regularity in people with Irritable Bowel Syndrome (IBS). Helps to relieve constipation and mild gastrointestinal discomfort in people with Irritable Bowel Syndrome (IBS). Helps to reduce the frequency of bowel irregularity and minor abdominal discomfort in people with Irritable Bowel Syndrome (IBS). Helps to relieve minor gastrointestinal symptoms associated with Irritable Bowel Syndrome (IBS) including flatulence, bloating, dyspepsia and altered bowel habits. Helps to relieve bowel irregularity, bloating and other minor gastrointestinal symptoms in people with Irritable Bowel Syndrome (IBS). Helps to improve intestinal regularity in children. Provides a gentle relief of constipation. Provides a gentle relief of constipation in children. Helps modulate stool conditions (from either loose or hard) to normal conditions. Helps reduce the need for laxative use.Helps reduce incidents of diarrhea. Helps reduce glycemic response and glycemic index when taken with food.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80123544

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line